상세 보기
자료 필터
자료유형
발행연도
2005 ~ 2031
2005 2031
키워드
언어
전체 358건 중 31번부터 40번까지의 결과를 표시합니다.
2025
Article
Immunogenicity and safety of quadrivalent recombinant influenza vaccine in Korean adults: Phase III, randomized study
- Choi, Won Suk ;
- Lee, Jacob ;
- Ottaviano, Cecilia ;
- Samson, Sandrine ;
- Peng, Lin ;
- ... Kim, Woo Joo ;
- 외 2명
- 2025-08
- Vaccine
- Elsevier BV
Article
Correction: Choi et al. Prioritization of Vaccines for Introduction in the National Immunization Program in the Republic of Korea. Vaccines 2024, 12, 886
- Choi, Won Suk ;
- Sung, Yeonhee ;
- Kim, Jimin ;
- Seok, Hyeri ;
- Choe, Young J. ;
- 외 5명
- 2025-08
- Vaccines
- Multidisciplinary Digital Publishing Institute (MDPI)
Article
Enhanced Diagnostic Accuracy for Septic Arthritis Through Multivariate Analysis of Serum and Synovial Biomarkers
- Park, Hyung Jun ;
- Jeon, Ji Hoon ;
- Song, Juhyun ;
- Seok, Hyeri ;
- Choi, Hee Kyoung ;
- ... Choi, Won Suk ;
- ... Nam, Myung-Hyun ;
- ... Suh, Dong Hun ;
- ... Kim, Jae Gyoon ;
- ... Park, Dae Won ;
- 외 1명
- 2025-08
- Journal of Clinical Medicine
- MDPI AG
Article
Shifts in Influenza and Respiratory Syncytial Virus Infection Patterns in Korea After the COVID-19 Pandemic Resulting From Immunity Debt: Retrospective Observational Study
- Park, Minah ;
- Choi, Won Suk ;
- Cowling, Benjamin J.
- 2025-07
- JMIR Public Health and Surveillance
- JMIR Publications
Article
Recommendations for Influenza Vaccination in Immunocompromised Patients
- Song, Joon Young ;
- Kwon, Ki Tae ;
- Park, Wan Beom ;
- Noh, Ji Yun ;
- Park, Sun Hee ;
- ... Choi, Min Joo ;
- ... Choi, Won Suk ;
- 외 3명
- 2025-06
- Infection and Chemotherapy
- Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy
Article
Real-world effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine: Analysis over nine months
- Nham, Eliel ;
- Song, Joon Young ;
- Sohn, Jang Wook ;
- Choi, Won Suk ;
- Wie, Seong-Heon ;
- ... Yoon, Jin Gu ;
- ... Noh, Ji Yun ;
- ... Cheong, Hee Jin ;
- ... Kim, Woo Joo ;
- 외 5명
- 2025-06
- Vaccine
- Elsevier BV